Sasaki S., Sakuma M., Kunihara T., et al: Current trends in thromboangiitis obliterans (Buerger's disease) in women. Am J Surg177:316-320, 1999.
2.
Lie JT: The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn39:153-158, 1989.
3.
Smoking-attributable mortality and years of potential life lost—United States, 1984. MMWR46:441-451, 1997.
4.
Disdier P., Granel B., Serratrice J., et al: Cannabis arteritis revisited—ten new case reports. Angiology52:1-5, 2001.
5.
Schneider F. , Abdoucheli-Baudot N., Tassart M., et al: Cannabis and tobacco: Cofactors favoring juvenile obliterative arteriopathy. J Mal Vasc25:388-389, 2000.
6.
Marder VJ, Mellinghoff IK: Cocaine and Buerger's disease: Is there a pathogenetic association ? Arch Intern Med160:2057-2060, 2000 .
Grobe VJ: Peripheral circulatory disorders and acrocyanosis in arsenic-exposed Moselle wine growers. Berufsdermatosen24:78-84, 1976.
9.
Mudur G.: Half of Bangladesh population at risk of arsenic poisoning. BMJ320:822, 2000.
10.
Tseng CH, Chong CK, Chen CJ, et al: Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in black-foot disease endemic villages in Taiwan. Atherosclerosis120:125-133, 1996.
11.
Narang AP, Greval RS, Goyal SC: Arsenic adulteration in Indian tobacco. Indian J Med Sci49:55-57, 1995.
12.
Hill GL, Moeliono J., Tumewu F., et al: The Buerger syndrome in Java. A description of the clinical syndrome and some aspects of its aetiology. Br J Surg60:606-613, 1973.
13.
Rahman M., Chowdhury AS, Fukui T., et al: Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: A case-control study. Int J Epidemiol29:266-270, 2000.
14.
Kalant H.: Opium revisited: A brief review of its nature, composition, non-medical use and relative risks. Addiction92:267-277, 1997.
15.
Lombard J., Levin IH, Weiner WJ: Arsenic intoxication in a cocaine abuser. N Engl J Med320:869, 1989.
16.
Pace LW, Tumquist SE, Casteel SW, et al: Acute arsenic toxicosis in five horses. Vet Pathol34:160-164, 1997.
17.
Labadie H., Stoessel P., Callard P., et al: Hepatic venoocclusive disease and perisinusoidal fibrosis secondary to arsenic poisoning. Gastroenterology99:1140-1143, 1990.
18.
Chiou HY, Huang WI, Su CL, et al: Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke28:1717-1723, 1997.
19.
Roboz GJ, Dias S., Lam G., et al: Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis . Blood96:1525-1530, 2000 .
20.
Kumar SV, Bhattacharya S.: In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: Influence of adenylate cyclase and phosphodiesterase activity. In Vitro Mol Toxicol13:137-144, 2000.
21.
Novick SC, Warrell RP Jr: Arsenicals in hematologic cancers. Semin Oncol27:495-501, 2000.
22.
Griffin RJ, Lee SH, Rood KL, et al: Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia2:555-560, 2000.
